AMGEN INC
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $36.8B | $33.4B | $28.2B | $26.3B | $26.0B |
| Operating income | $9.1B | $7.3B | $7.9B | $9.6B | $7.6B |
| Cost of revenue | $12.0B | $12.9B | $8.5B | $6.4B | $6.5B |
| Cash from operations | $10.0B | $11.5B | $8.5B | $9.7B | $9.3B |
| Capital expenditure | $1.9B | $1.1B | $1.1B | $936.0M | $880.0M |
| Free cash flow | $8.1B | $10.4B | $7.4B | $8.8B | $8.4B |
| Share repurchases | $0 | $200.0M | $0 | $6.4B | $5.0B |
| Impairments | $1.2B | — | — | — | — |
| Total assets | $90.6B | $91.8B | $97.2B | $65.1B | $61.2B |
Shares outstanding 539.7M · Free float 99.8%
Annual filing data through FY ended December 31, 2025; float as of July 8, 2026.
Recent filings
- May 20, 2026 8-K
- May 19, 2026 8-K
- May 1, 2026 10-Q
- April 30, 2026 8-K
- April 22, 2026 8-K
- February 19, 2026 8-K
- February 13, 2026 10-K
- February 3, 2026 8-K